Tylidys Lapatinib 250mg Tablet

Trade Name: Tylidys

Manufacturer: Cipla

Presentation: Tablet

Strength: 250mg

What is the purpose of lapatinib?

Lapatinib is a drug that is used with capecitabine (Xeloda) to treat a specific form of advanced breast cancer in persons who have already had various types of chemotherapy.

What are the Tylidys adverse effects?

  • Nausea
  • vomiting
  • stomach discomfort
  • mouth sores
  • minor rash
  • dry skin and difficulty sleeping are all possible side effects.
  • If any of these adverse effects persist or worsen, contact your doctor or pharmacist right away.
  • Diarrhea is a typical side effect that can get quite bad.

to know more click here

Which of the following test results is the most crucial to know before starting Tylidys treatment?

Before starting treatment, liver function tests (transaminases, bilirubin, and alkaline phosphatase) should be checked, as well as every 4 to 6 weeks during treatment and as clinically required.

What is the nature of her breast cancer that is positive?

Breast cancer that tests positive for the protein human epidermal growth factor receptor 2 is known as HER2-positive breast cancer (HER2). This protein encourages cancer cell proliferation. Extra copies of the gene that produces the HER2 protein are found in around one out of every five breast tumors.

What is lapatinib’s alternative name?

The generic name for the brand-name medicine Iressa® is gefitinib. When referring to the generic medicine name gefitinib, health care providers may use the commercial name Iressa ®.

What is lapatinib injection and how does it work?

lapatinib is a drug that is used to treat cancers of the breast, stomach, and esophagus. This medicine is used to treat cancers that produce an excessive amount of a chemical known as HER2 protein. Trastuzumab is a monoclonal antibody, which means it belongs to a class of drugs called monoclonal antibodies.

What is the composition of lapatinib?

lapatinib was developed from a murine monoclonal antibody (muMAb A4. 6.1) developed at Genentech utilizing hybridomas obtained from mice immunized with a 165-residue version of recombinant human vascular endothelial growth factor (rhuVEGF165) coupled with keyhole limpet hemocyanin.

What is the dosage of lapatinib?

In a recurring 21-day cycle, the recommended dose of TYKERB is 1,250 mg given orally once daily on Days 1-21 in combination with capecitabine 2,000 mg/m2/day (provided orally in two doses roughly 12 hours apart) on Days 1-14. At least one hour before or after a meal, TYKERB should be consumed.

We are a global wholesaler and exporter from India and operate in more than 5 countries like the United Arab Emirates, the United States of America, Italy, Germany, Indonesia, etc. if you are more products or more detail